FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and represents a biodegradable polymer carrier for the delivery of an anti-cancer drug with its macromolecule having a linear chain configuration and consisting of links of general formula 
wherein m=1 or 2; the molecular mass of the polymer carrier is 10000 to 200000 Da.
EFFECT: invention provides creating the new biodegradable polymer carrier able for chemical or physical binding to the anti-cancer drug to form easily degradable bonds in the human physiological environments.
2 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIODEGRADABLE POLYMER CARRIER FOR ANTI-CANCER DRUG DELIVERY (VERSIONS) | 2012 |
|
RU2500428C1 |
| METHOD OF OBTAINING BLOCK-COPOLYMERS AND INITIATOR-2,2-DI(AMIDOAMINOACETIC ACID)DIPHENYLDISULFIDE FOR EFFECTING THE METHOD | 0 |
|
SU664970A1 |
| GLYCOPOLYSIALYLATION OF PROTEINS THAT ARE NOT THE PROTEINS OF THE BLOOD CLOTTING | 2014 |
|
RU2662807C2 |
| PEPTIDE COPOLYMER, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITION BASED ON SAID COPOLYMER | 2009 |
|
RU2402576C1 |
| POLYGLUTAMATE-AMINO ACID CONJUGATES AND METHODS | 2006 |
|
RU2472812C2 |
| IMPROVED METHOD FOR PREPARING HYDRAZIDES | 2008 |
|
RU2484849C2 |
| PHARMACEUTICAL COMPOSITION, CONTAINING BLOCK-COPOLYMER, INCLUDING BORONIC ACID COMPOUND | 2012 |
|
RU2569847C2 |
| DOLOSTATINE ANALOG | 1993 |
|
RU2132334C1 |
| CONJUGATE OF GLYCOPROTEIN, POSSESSING ERYTHROPOIETIN ACTIVITY, WITH POLY-1,4-ETHYLENEPIPERAZINE N-OXIDE DERIVATIVES (VERSIONS), PHARMACEUTICAL COMPOSITION AND METHOD OF CONJUGATE OBTAINING | 2013 |
|
RU2556378C2 |
| GLYCOPOLYSIALYLATION OF PROTEINS, WHICH ARE NOT BLOOD CLOTTING PROTEINS | 2010 |
|
RU2533619C2 |
